Invention Grant
- Patent Title: Glycopegylated erythropoietin
-
Application No.: US11144223Application Date: 2005-06-02
-
Publication No.: US08633157B2Publication Date: 2014-01-21
- Inventor: Shawn DeFrees , Robert J. Bayer , David A. Zopf
- Applicant: Shawn DeFrees , Robert J. Bayer , David A. Zopf
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61P7/06 ; C07K14/505

Abstract:
The present invention provides conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
Public/Granted literature
- US20100210507A9 Glycopegylated erythropoietin Public/Granted day:2010-08-19
Information query
IPC分类: